Patients, Caregivers AND Physicians saw a great Difference.
That is what sticks in my mind and they wanted to continue with the drug.
This you Can NOT ignore. It could end up as a failure, but you cannot ignore this, just Can't!
I agree. This is just the VERY Beginning if any of you understand just what they have....and it's powerful...and it will be a candidate for many, many treatments to come.
It's difficult seeing your account with huge gains, trust me I KNOW, but if you are thinking long term...the sky is the limit on this one and once more institutions buy it will explode up.
You can be a penny flipper or hold and pay a lot less taxes and receive many fold the reward in share price.
Do your research as Ranger says, their entire platform is loaded with Goodies that is likely to treat multiple CNS diseases. Very True.
Don't count out Chronic Fatigue Syndrome in which I strongly believe this could help and I will expand on this much later as I want an interview with Dr. Missling first.
Do you have any idea when they will meet with FDA to receive guidance on what they can do, like file for NDA?
I like the chart Tex, that is one big reason why I am still holding.
I am not sure what to think about what the FDA will say, but they did meet stat sig in the longer term, which is really what should matter.
I'm new to this board and NYMX, any comments would be appreciated.
I sold all of SYN and went in AVXL at .48 cents, so I'd say it's PAYING off Big time.
When or if I sell, I may take some profits back here.
I've made $50,000 in AVXL in the past 3 weeks and it's still going up.
Eventually will add some of that here.
That's for Sure Bocamp...and what hurts the most is....Our Research and Due Diligence was absolutely Right on. It was management that completely didn't know what they were doing but the Science was Outstanding.
Yeah, better late than never.
This "Aint" your Normal stock buddy. Can tell you don't even remotely understand what's going on here.
Buying at this level will make people a lot of money by the end of year.
Correct, this is just ole fashioned low float with a lot of accumulation and little distribution.
This is way undervalued and could have a Billion market cap by EOY with more news.
They are running out of shares, just like in the stock TRIL....same thing happened and it went up over 4 fold before they finally had some distribution.
You have been saying this since this was in the 70 and .80 cent range.
I told you to learn how to read a chart and told you that the chart was not even Close to topping out.
Before you go telling everyone to sell...learn both the fundamentals and the technicals.
This company doesn't have a high float so even retailers can drive this WAY up. Wait until the institutions come.
You will see $5.00 in a flash.
Oh yeah, regarding PRANA, I know all about it and this is a total different Mechanism of Action...Pran didn't have results like this, they tried to spin the heck out of them, but they didn't.
Why does hiring a CFO speak Volumes? If it was prior to the release of Positive News I could understand, but all it has spoken is volumes of Sellers.
CUR has lost touch with their shareholders and they are suffering for that.
You trust their silence? What? Really?
They have had PLENTY of time to analyze results and give us more information...are they hiding something?
Silence in a biotech usually means there is nothing good to tell the shareholders. I am a shareholder and want to know just what the heck is going on.
I don't trust the silence.
We need some NEWS ASAP.
You know this is a Disclaimer found in Every one of the Clinical Stage Biopharm sector.
You are obviously a paid Basher, but is this something Personal with you or one of your bosses?
These so called "Scare Tactics" ... do you really think such immature, absurd bashing will fool a true investor? Or are you just after the small retailers on your intellectual level?
You post as it is personal...almost intimately personal.
Did you drop the soap in the shower and bend over...only to feel Kriegsman #$%$ up you #$%$?
So you got bent the REAL way by the nasty old CEO.
Jeesh, I'd be bashing like crazy too!
Funny, that's what I was just thinking.
Do you still have any of this Paul?
I think they have something that could possibly treat depression and that could really add value some day.
Since Garr won't ever say anything, you cannot tell what is going on. They should fire him, probably a nice guy but nice doesn't make a good CEO, which in my personal opinion he is NOT!
ALS --- the last trial news just proved that this is Nowhere close to what they thought this would be 3-5 years ago, in fact some patients progressed faster--which is weird, possibly from the surgery trauma. So I have no clue what will end up occurring with this, it's quite a procedure and EVERYONE expected much better results. Is it clinical meaningful? For some, possibly.
You still in AVXL --- that has been my best investment this year and I think it could be $4 to $5 by End of Year and a Very Strong Buy right now.
As far as CUR goes --- they may really have something for their Depression drug or possible experimenting with some CNS disorders.
NSI-189 is and has been the most interesting aspect of CUR as I am interesting in seeing where they can take this, but the problem is we Never hear anything. The Company needs to keep shareholders involved and knowing even the little things that they are working on.
If they announce that they are dropping 566 that could make this a very attractive buy as I believe there would be an overreaction of selling...the problem is we don't know the discussions between FDA.
Totally Agree with you.
If phase II- confirms this, then it could be much more than a Billion. BIIB's market cap rose $10 BILLION just because they "Thought" they had something...until AVXL came out and just blew everyone away in data.
We will be saying goodbye to the $1's here.